Verve Therapeutics shares owned by Redmile Group
Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Redmile Group
from 13F filings
Historical chart of Redmile Group investment in Verve Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Verve Therapeutics held by Redmile Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Verve Therapeutics by Redmile Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $24M | 1.7M | 13.94 |
2023-09-30 | $11M | 810k | 13.26 |
2023-06-30 | $20M | 1.1M | 18.75 |
2023-03-31 | $16M | 1.1M | 14.42 |
2022-12-31 | $24M | 1.2M | 19.35 |
2022-09-30 | $52M | 1.5M | 34.35 |
2022-06-30 | $28M | 1.8M | 15.28 |
2022-03-31 | $42M | 1.8M | 22.82 |
2021-12-31 | $63M | 1.7M | 36.87 |
2021-09-30 | $88M | 1.9M | 47.00 |
2021-06-30 | $117M | 1.9M | 60.25 |